Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus

Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus

Abstract Background Ovarian clear cell carcinoma (OCCC) accounts for approximately 8–10% of epithelial ovarian cancers in the United States. Although it is rare, OCCC usually presents with treatment challenges and the overall prognosis is far worse than high grade serous ovarian cancer HGSOC. The ob...

Full description

Bibliographic Details
Main Authors: Uksha Saini, Brentley Q. Smith, Kalpana Deepa Priya Dorayappan, Ji Young Yoo, G. Larry Maxwell, Balveen Kaur, Ikuo Konishi, David O’Malley, David E. Cohn, Karuppaiyah Selvendiran
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Journal of Ovarian Research
Subjects:
TMEM205
Oncolytic virus
Exosomes
Clear cell carcinoma
Platinum resistant
Online Access:https://doi.org/10.1186/s13048-022-01054-5

Internet

https://doi.org/10.1186/s13048-022-01054-5

Similar Items